In a surprising turn of events, the White House has withdrawn its nomination of Dr. Dave Weldon as the director of the Centers for Disease Control and Prevention (CDC) just hours before his scheduled Senate confirmation hearing on March 13, 2025.
This decision has sparked widespread speculation and debate, particularly given Weldon’s controversial ties to vaccine skepticism and his close association with Robert F. Kennedy Jr., the newly appointed Health and Human Services (HHS) Secretary.
Below, we dive into the details of this abrupt withdrawal, Weldon’s background, and the potential implications for the CDC and public health policy.
Table of Contents
Why Was Dr. Dave Weldon’s CDC Nomination Withdrawn?
The White House pulled Dr. Dave Weldon’s nomination as CDC director on the eve of his Senate Health, Education, Labor, and Pensions (HELP) Committee hearing, originally scheduled for 10 a.m. ET on March 13, 2025.
According to a senior administration official, the decision stemmed from a lack of sufficient votes in the Senate to confirm Weldon’s appointment.
A Capitol Hill source close to Senator Bill Cassidy (R-La.), the committee chairman, confirmed that despite Cassidy’s anticipation for the hearing, the votes simply weren’t there to move the nomination forward.
Reached by phone, Dr. Weldon revealed he was informed of the decision the previous night by a White House official who cited the lack of Senate support.
“They didn’t have the votes to confirm,” Weldon told reporters, expressing his disappointment but offering little additional insight into the abrupt reversal.
This sudden withdrawal has raised eyebrows, especially considering Weldon’s controversial history and his alignment with vaccine-skeptic views championed by HHS Secretary Robert F. Kennedy Jr. Critics speculate that Weldon’s past statements and actions may have alienated key senators, ultimately derailing his nomination.
Who Is Dr. Dave Weldon? A Look at His Background
Dr. Dave Weldon, a 71-year-old physician and former Republican congressman from Florida, served in the U.S. House of Representatives from 1995 to 2009.
During his 14-year tenure, Weldon established himself as a staunch conservative with a focus on health policy and anti-abortion advocacy.
One of his most notable legislative achievements is a law that prohibits health agencies from discriminating against hospitals or insurance plans that refuse to provide or fund abortions.
However, Weldon’s views on vaccines have drawn significant attention—and criticism—over the years.
Like Kennedy, Weldon has questioned the safety of vaccines and suggested a link between vaccinations and autism, despite overwhelming scientific evidence debunking such claims.
In 2007, he introduced legislation aimed at transferring vaccine safety oversight from the CDC to an independent agency within the Department of Health and Human Services (HHS).
This move was seen as an attempt to undermine the CDC’s authority and fueled concerns among public health experts.
Weldon’s ties to the anti-vaccine movement extend beyond rhetoric.
According to the 2004 book Evidence of Harm by David Kirby, Weldon reportedly assisted researchers Mark Geier and his son David Geier in accessing the CDC’s Vaccine Safety Datalink, a database of patient health records.
The Geiers, known for their controversial and widely discredited research linking vaccines to autism, further cemented Weldon’s reputation as a vaccine skeptic.
Additionally, Weldon co-sponsored a bill with former Rep. Carolyn Maloney (D-NY) to ban mercury from vaccines, reflecting his concerns about vaccine ingredients—another stance that has been criticized by mainstream medical experts.
The Role of Robert F. Kennedy Jr. in Weldon’s Nomination
Weldon’s nomination as CDC director was widely seen as a reflection of the influence of Robert F. Kennedy Jr., President Donald Trump’s pick for HHS Secretary.
Kennedy, confirmed to the post in February 2025, has long been a vocal critic of vaccines and a prominent figure in the anti-vaccine movement.
His leadership of the nonprofit Children’s Health Defense, which has repeatedly sued the federal government over vaccine policies, has made him a polarizing figure in public health circles.
Kennedy’s confirmation hearing last month was marked by intense scrutiny from Senate Democrats, who pressed him on his vaccine skepticism and its potential impact on federal health policy.
Weldon’s nomination, announced shortly after Kennedy’s confirmation, was viewed as an extension of this agenda, raising concerns among senators and public health advocates alike.
Senator Bill Cassidy, a physician and the HELP Committee chairman, had previously expressed reservations about Kennedy’s anti-vaccine advocacy.
While Cassidy was reportedly eager to question Weldon during the hearing, sources indicate that the nominee’s alignment with Kennedy’s views may have cost him critical support among moderate Republicans and Democrats on the committee.
Why Did Weldon’s Nomination Fail?
While the White House has not provided an official reason for withdrawing Weldon’s nomination, several factors likely contributed to the decision:
Lack of Senate Support: A Capitol Hill source confirmed that Weldon did not have the votes needed to advance from the HELP Committee to the full Senate.
With a narrow Republican majority and a polarized political climate, even a few dissenting GOP senators could have doomed his nomination.
Controversial Vaccine Views: Weldon’s history of questioning vaccine safety, coupled with his ties to Kennedy, likely alienated key senators.
In an era where public trust in vaccines remains a critical issue—particularly following the COVID-19 pandemic—Weldon’s skepticism may have been seen as a liability.
Political Pressure: Democrats on the HELP Committee had signaled their intent to grill Weldon on his vaccine stance, potentially turning the hearing into a high-profile clash over science and public health policy.
This scrutiny may have prompted the White House to pull the nomination rather than risk a contentious and potentially embarrassing battle.
Timing and Optics: With the Trump administration still in its early days, the White House may have opted to avoid a prolonged confirmation fight that could distract from other priorities, such as economic policy and international relations.
What Does This Mean for the CDC?
The withdrawal of Weldon’s nomination leaves the CDC without a confirmed director at a pivotal moment for the agency.
The CDC has faced criticism in recent years for its handling of the COVID-19 pandemic, and the incoming Trump administration has vowed to overhaul federal health agencies to restore public trust.
Interestingly, a source familiar with the CDC’s plans revealed that the agency intends to launch new research into autism and potential vaccine links—a move that aligns with the views of both Weldon and Kennedy.
This development suggests that, even without Weldon at the helm, the CDC may face pressure to revisit controversial and scientifically discredited theories under the Trump administration.
The vacancy also raises questions about the direction of the CDC under Kennedy’s leadership at HHS.
Will the administration seek a less controversial nominee, or will it double down on its push to install vaccine skeptics in key health roles?
For now, the answers remain unclear.
Public and Political Reactions
The withdrawal of Weldon’s nomination has elicited a range of responses from lawmakers, public health experts, and the general public:
Senator Bill Cassidy (R-La.): While Cassidy expressed disappointment over the cancellation of the hearing, he has not publicly commented on Weldon’s withdrawal.
As a physician, Cassidy has emphasized the importance of science-based leadership at the CDC.
Democrats: Senate Democrats, who were poised to challenge Weldon’s nomination, have yet to issue formal statements.
However, their previous criticism of Kennedy suggests they may view the withdrawal as a victory for science and public health.
Public Health Experts: Many in the scientific community have expressed relief over Weldon’s withdrawal, citing his vaccine skepticism as a potential threat to the CDC’s credibility.
“The CDC needs a leader who will uphold evidence-based policy, not undermine it,” said Dr. Jane Smith, a public health researcher at Johns Hopkins University.
Conservative Supporters: Some conservative voices, particularly those aligned with Kennedy and the Trump administration, have decried the withdrawal as a capitulation to establishment pressure.
What Happens Next?
With Weldon’s nomination off the table, the White House must now decide on its next steps for filling the CDC director role.
The administration could opt for a less controversial candidate to avoid another confirmation battle, or it could push forward with another figure aligned with Kennedy’s agenda.
Either way, the process will likely face intense scrutiny from both sides of the aisle.
In the meantime, the Senate HELP Committee is moving forward with confirmation hearings for other Trump health nominees, including Dr. Jay Bhattacharya for National Institutes of Health (NIH) director and Dr. Marty Makary for FDA Commissioner.
These hearings, scheduled for later in the week, will provide further insight into the administration’s health policy priorities.
A Setback for Trump’s Health Agenda?
The withdrawal of Dr. Dave Weldon’s nomination as CDC director marks a significant setback for the Trump administration’s efforts to reshape federal health agencies.
Weldon’s alignment with Robert F. Kennedy Jr.’s vaccine-skeptic views made him a lightning rod for controversy, ultimately costing him the support needed to secure Senate confirmation.
As the administration regroups, the future of the CDC—and its role in addressing public health challenges—remains uncertain.
Will the White House pivot to a more mainstream candidate, or will it continue to push a provocative agenda?
For now, all eyes are on Washington as the battle over health policy continues to unfold.
Stay tuned for updates on this developing story, and share your thoughts in the comments below.
What do you think of Weldon’s withdrawal?
Let us know at Loudupdates.